Tesamorelin (10mg)

55,00 

TECHNICAL SPECIFICATIONS

Property Specification
Compound Name Tesamorelin
Purity (HPLC) ≥ 98.0%
Physical State Lyophilized Powder
Vial Content 10mg
Sequence Modified GHRH (1-44)

1. PRODUCT OVERVIEW

Tesamorelin is a stabilized synthetic peptide analog of Growth Hormone-Releasing Hormone (GHRH 1–44). Featuring a trans-3-hexenoic acid modification at the N-terminus, it exhibits enhanced stability and potent binding affinity for GHRH receptors. It is a primary tool in endocrine research for investigating growth hormone (GH) synthesis, somatotropic axis regulation, and receptor-ligand interaction kinetics.

 

2. STORAGE & HANDLING

Long-term Storage: Keep lyophilized powder at -20°C (-4°F). Protect from light exposure and moisture.

Post-Reconstitution: Store the liquid solution at 2–8°C (36–46°F). For optimal experimental integrity, use within 30 days of reconstitution.

Handling: Avoid vigorous vortexing; gentle swirling is recommended during dissolution.

3. POTENTIAL RESEARCH APPLICATIONS

GHRHR Pharmacology: Assaying ligand potency, binding affinity, and receptor-activation thresholds.

Signaling Pathways: Measuring second-messenger responses, specifically the adenylate cyclase/cAMP-linked cascades.

Somatotropic Mapping: Detailed investigation of the GH/IGF-1 axis feedback loops in controlled in-vitro and in-vivo models.

Metabolic Research: Exploratory workflows focused on neuroendocrine signaling and energy balance biomarkers.

4. REGULATORY DISCLAIMER

NOTICE: This material is supplied strictly for laboratory research and development. It is NOT FOR HUMAN CONSUMPTION, nor for any therapeutic, clinical, or diagnostic applications. Handling must be performed by qualified scientific personnel only.

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin (10mg)”

Your email address will not be published. Required fields are marked *

Shopping Cart